Atupan, Emelyn G.
HRN: 22-81-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/31/2023
CEFUROXIME 1.5GM (VIAL)
04/01/2023
04/01/2023
IV
1.5
Q8 X 2 More Dose + Replacement
S/P Primary LSTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes